Valuation: Captor Therapeutics Spolka Akcyjna

Market Cap 463M 122M 107M 99.08M 91.85M 172M 11.78B 175M 1.18B 5.76B 460M 450M 19.9B P/E 2026 *
23.7x
P/E 2027 * -280x
Enterprise Value 391M 103M 90.41M 83.57M 77.47M 145M 9.93B 148M 997M 4.86B 388M 379M 16.78B EV / Sales 2026 *
6.89x
EV / Sales 2027 * 8.12x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 day-0.82%
1 week-2.80%
Current month-4.83%
1 month-7.60%
3 months-7.37%
6 months-7.02%
Current year+1.25%
1 week 71.5
Extreme 71.5
75.5
1 month 71.5
Extreme 71.5
79
Current year 70.2
Extreme 70.2
89.2
1 year 33
Extreme 33
89.2
3 years 31.2
Extreme 31.2
147
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 2025-05-30
Director of Finance/CFO - 2025-01-31
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Chairman 54 2022-06-29
Director/Board Member 74 2022-06-29
Director/Board Member - 2022-06-29
Date Insider Type Main position Quantity % Market Cap.
02-25Buy 1,100 0.0198%
12-11Free

Chairman

360,074 6.5128%
12-11Free

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%-2.80%+76.51%-50.07% 123M
-1.05%+1.39%+3.15%+6.98% 50.61B
+0.55%-2.88%+382.07%+593.81% 39.11B
+0.13%-0.19%+29.79%-6.00% 34.64B
+0.86%-0.78%+21.58%+56.15% 33.79B
-1.31%-3.03%+2.51%+25.24% 26.89B
+0.13%-0.52% - - 16.47B
+1.13%-1.85%+67.36%+120.46% 15.14B
-0.72%+0.12%+14.69%+16.95% 13.85B
+1.13%-0.44%+12.34%-31.79% 12.72B
Average +0.00%-1.68%+67.78%+81.30% 24.33B
Weighted average by Cap. -0.04%-1.14%+80.75%+121.62%

Financials

2026 *2027 *
Net sales 56.7M 14.99M 13.12M 12.13M 11.24M 21.11M 1.44B 21.48M 145M 705M 56.25M 55.03M 2.44B 48.5M 12.83M 11.22M 10.37M 9.62M 18.06M 1.23B 18.37M 124M 603M 48.12M 47.07M 2.08B
Net income -3M -793K -694K -642K -595K -1.12M -76.27M -1.14M -7.66M -37.28M -2.98M -2.91M -129M -1.5M -397K -347K -321K -297K -559K -38.13M -568K -3.83M -18.64M -1.49M -1.46M -64.43M
Net Debt -72.5M -19.17M -16.78M -15.51M -14.38M -26.99M -1.84B -27.46M -185M -901M -71.93M -70.37M -3.11B -69.5M -18.38M -16.09M -14.87M -13.78M -25.88M -1.77B -26.33M -177M -864M -68.95M -67.45M -2.99B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
82
Date Price Change Volume
26-07-14 PLN 72.90 -0.82% 5,747
26-07-13 PLN 73.50 -2.52% 4,953
26-07-10 PLN 75.40 -0.13% 2,333
26-07-09 PLN 75.50 +2.03% 1,649
26-07-08 PLN 74.00 -1.33% 2,110
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
72.90PLN
Average target price
86.83PLN
Spread / Average Target
+19.11%

Quarterly revenue - Rate of surprise